Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

MoFo Shortlisted for 12 Awards at The Legal 500 China Awards 2026

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

Morrison Foerster has been shortlisted for twelve awards at The Legal 500 China Awards 2026. The award series is set to recognize...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison Foerster has been shortlisted for twelve awards at The Legal 500 China Awards 2026. The award series is set to recognize the leading firms and lawyers together with the younger rising talent who are part of China’s extensive and complex legal market, based on The Legal 500’s independent research.The categories in which Morrison Foerster has been shortlisted include:<ul><li>Data Protection: Foreign Firms – Firm of the Year</li><li>Investment Funds: Foreign Firms – Firm of the Year</li><li>Leading Firm of the Year: Foreign Firms</li><li>Life Sciences and Healthcare: Foreign Firms – Firm of the Year</li><li>Private Equity: Foreign Firms – Firm of the Year</li><li>TMT: Foreign Firms – Firm of the Year</li><li>Deal of the Year – Private Equity: Foreign Firms, for advising Boyu Capital on its joint venture with Starbucks to operate Starbucks’ retail business in China, valuing the business at approximately US$4 billion, one of the largest private equity transactions in China’s consumer sector in 2025</li></ul>Additionally, the following MoFo lawyers have been shortlisted in their respective categories:<ul><li>Marcia Ellis — Private Equity: Foreign Firms – Lawyer of the Year</li><li>Derik Rao — Regulatory: Foreign Firms – Lawyer of the Year</li><li>Chuan Sun — Managing Partner of the Year: Foreign Firms; and Data Protection: Foreign Firms – Lawyer of the Year</li><li>Serena Tan — Investment Funds: Foreign Firms – Lawyer of the Year</li></ul>With offices in Shanghai and Hong Kong, Morrison Foerster has a strong presence in China, handling major matters in the region for more than 40 years. We were among the first U.S. law firms to establish offices in China’s major business centers. We have about 50 U.S.-, Hong Kong-, PRC-, and England and Wales-qualified professionals, who work closely with attorneys throughout the firm to deliver calibrated and sound advice to clients. We counsel a wide variety of clients in China on their most high-profile investments, as well as on finance and regulatory matters. Our clients include many of the world’s largest multinationals, private equity/real estate/venture/credit fund managers, institutional investors, and the most substantial and active institutional companies in the region. We provide legal advice to companies across a broad range of sectors, including technology, life sciences, data centers, financial institutions, AI, fintechs, digital media, food & agriculture, and semiconductors.To view the full shortlist, please visit <a href="https://www.legal500.com/events/china-awards/shortlist-2025/" target="_blank">The Legal 500’s website</a>.

MoFo Shortlisted for 12 Awards at The Legal 500 China Awards 2026

Sign Up

Marcia Ellis is a Senior Counsel in our New York office and a Partner in our Hong Kong office. Marcia’s practice focuses on private equity transactions and complex mergers and acquisitions involving companies and other assets located in Asia. Having practiced in Asia for more than a quarter of a century, Marcia is one of the most experienced M&A lawyers active in the Asian market. In the past three years, she has advised clients on deals with a total aggregate value well in excess of US$249.8 billion.​Marcia regularly advises leading investors on M&A transactions, including SoftBank Vision Fund, Alibaba, GLP, Bain Capital, BlackRock, Farallon Capital, Ascendent Capital Partners, Silver Crest Acquisition Corp., PAG, Hillhouse, Hony Capital and Celadon Partners. In addition, she is experienced in representing U.S., UK and Asia based institutional investors in the acquisition, financing and disposition of real estate in China, Hong Kong and elsewhere in Asia, including numerous logistics and internet data center projects, and investment in and acquisition of real estate developers.From 2008 through 2011, she was the Chief Legal Officer for Asia of D. E. Shaw, where she assisted various group entities in making, restructuring, and exiting investments in various countries in Asia, including a number of significant and highly structured investments in China and India.Clients consider Marcia as a "super skilled technical lawyer" who offers "incredible problem-solving skills on all aspects of matters, both legal and commercial". A client said that "Finding a lawyer whose judgement you trust and who knows how far they can push the boundaries is not easy, and Marcia is the best lawyer I've worked with."Marcia is a member of our global board of directors and a member of our global Environmental, Social and Governance (ESG) Steering Committee. She served as a Global Co-Chair of the firm's Private Equity Practice. In 2022, she spearheaded the launch of MoFo’s annual survey of the ESG and DEI policies and practices of Asia-headquartered PE firms. She has also been named to Law360’s 2022 and 2023 Private Equity Editorial Board and elected as the Co-Chair of AmCham Hong Kong’s Women of Influence Committee. Marcia has been recognized as one of the Women of Influence in Private Markets: Private Equity by Private Equity International in 2024.

Marcia Ellis（艾琳）律师的执业重点是涉及亚洲境内公司和其它资产的私募股权交易和复杂并购。Ellis律师在亚洲执业超过二十五年，是活跃在亚洲市场经验最丰富的并购律师之一。在过去三年间，她为客户完成的交易的合计价值超过2498亿美元。Ellis律师经常为大型投资者提供并购交易法律咨询，这些投资者包括软银愿景基金、阿里巴巴、普洛斯、Bain Capital、贝莱德、Farallon Capital、上达资本、Silver Crest特殊目的收购公司、PAG、高瓴资本、弘毅投资以及Celadon Partners。此外，在代表美国、英国、亚洲机构投资人方面她也富有经验；她代表客户处理收购、融资、处置中国、香港及亚洲其它地区的房地产，其中包括许多物流和互联网数据中心项目，也处理对房地产开发商的投资与收购。从2008至2011年，Ellis律师是德劭集团亚洲区的首席法务官。在德劭集团，她协助各集团实体处理在亚洲多个国家进行的投资、投资重组及投资退出事宜，包括在中国和印度进行的多个重要及高度结构化的投资。客户评价Ellis律师是一位"技巧高超的律师"，她拥有 "极其出色的解决问题的能力，包括法律问题和商业问题 "。一位客户称："找到一位拥有令人信任的判断力，并能尽力突破极限的律师并不容易，而她是我合作过的最好的律师"。Ellis律师是美富律师事务所的全球董事会成员，兼本所全球环境、社会与治理(ESG)指导委员会委员之一。她曾任本所的全球私募股权业务联席主席。在2022年，她率先发起了美富对总部位于亚洲的私募股权公司的环境、社会与治理以及可持续性的政策与实践的年度调查。她还当选《法律360》(Law 360)2022年度和2023年度私募股权业务编辑委员会成员，以及香港美国商会最具影响力女性(WOI)指导委员会联席主席。Ellis律师还荣获Private Equity International评为2024年“私募股权领域：私募市场最具影响力女性”之一。

Marcia Ellis

Senior Counsel (New York) | Partner (Hong Kong)

饶宇律师的执业范畴主要包括合规、监管、制裁、白领罪案事宜，以及《反海外腐败法》（FCPA）相关调查事宜。饶律师协助美国、中国、日本和欧盟的科技、医疗保健及金融及其他行业客户管理监管和合规风险。他与美富的美国、英国和欧盟团队紧密合作，代表客户处理一些最为复杂的监管问询，其中涉及美国司法部（DOJ）、美国财政部海外资产控制办公室（OFAC）、美国证券交易委员会（SEC）和美国外国投资委员会（CFIUS），以及中国商务部、国家发改委、国家网信办，以及其他政府机构。饶律师还协助跨国公司针对新出现的制裁、出口管制和其他法规，构建其监管合规体系。饶律师就涉及伊朗、俄罗斯、中国大陆、香港地区及其他司法管辖区的制裁和国家安全事宜，提供全面的风险评估。饶律师协助美国和欧洲领先的医疗保健、科技、工业、投资组合及咨询公司处理一些最具影响力的内部调查，拥有丰富经验。他的业务经常涉及举报、合规监督、主动披露以及与美国司法部的谈判。他在调查跨国公司面临的热门问题方面也有丰富的经验，包括反贿赂、反垄断、数据隐私、数据出口、挪用公款和会计欺诈。此外，饶律师曾在各类证券集体诉讼、监管机构调查及平行诉讼中，为多家纽约证券交易所上市公司进行辩护。他还针对美国刑事和民事诉讼（包括证券集体诉讼、监管调查以及与电信欺诈、内幕交易、经济间谍和盗取知识产权有关的刑事诉讼）为中国大陆、香港地区和新加坡的个人客户进行辩护。<h4>具有代表性的项目</h4><h5>内部和政府调查</h5><ul><li>代表一家位于美国的世界领先医药公司处理与其在中国、韩国以及欧洲、中东和非洲地区的运营相关的内部调查和补救项目。</li><li>代表一家位于美国的《财富500强》医疗保健公司处理与其在中国的运营相关的各项内部调查事宜，其中涉及反贿赂、挪用公款、数据隐私和会计欺诈等问题。</li><li>代表一家领先的《财富》100 强制药公司在韩国针对向非营利性医疗协会捐款进行内部调查。</li><li>代表一家半导体科技机构的审计委员会对前高管和员工的涉嫌欺诈及相关不当行为进行调查。</li><li>代表一家世界领先的音乐公司处理涉及其中国子公司的敏感内部调查。该调查涉及该子公司的最高层管理人员的潜在刑事责任。</li><li>代表一家在欧洲上市的全球医疗科技公司的中国子公司处理中国大陆、台湾地区和香港地区的反腐败及其他合规事宜。美富团队对其合规体系进行系统性审查，并强化其政策、程序和电子审批系统。</li><li>代表一家总部位于美国的《财富》 200强食品和农业公司就在中国的业务进行内部调查，调查内容涵盖客户采购的不当利益、挪用公司资金和费用欺诈等。</li><li>代表一家世界领先的专业服务公司处理与在中国的违反美国FCPA指控有关的内部调查和政府调查，美富团队成功获取美国司法部的不起诉决定。</li><li>代表一家位于欧洲的领先医疗设备公司针对在中国的运营起草合规指引以及提供合规培训。</li><li>代表一家在纳斯达克证券交易所上市的欧洲医疗保险公司处理针对其在中国的运营实施的六个月合规补救项目。</li><li>代表一家在纽约证券交易所上市的全球领先工业应用涂料供应商处理内部调查事宜。该等调查涉及对该公司中国子公司的高级管理层涉嫌贿赂、腐败、自我交易、围标、与分销商或供应商勾结、费用欺诈及其他不当行为的指控。</li><li>代表一家在纽约证券交易所上市、总部位于美国的全球领先化学品供应商，就其中国员工涉嫌商业贿赂、自我交易、侵占公司资产等指控开展内部调查。</li></ul><h5>国家安全/制裁和出口管制</h5><ul><li>代表一家总部位于美国的全球最大的人工智能技术公司之一处理多项内部调查、监管问询及危机管理，其中涉及出口管制、数据隐私及国家安全审查等事宜。</li><li>代表中国内地/香港某最大的金融机构之一就针对中国的各种经济制裁制度（包括美国和欧盟的制裁制度）提供及时和深入的合规建议。</li><li>为中国五大国有银行中的三家银行提供与美国制裁相关的法律服务，其中包括应对OFAC传票、执行内部调查、以及评估与美国制裁相关的交易风险等。</li><li>代表中国最大的国有跨国商业银行之一处理与美国针对多个法域的制裁制度有关的制裁合规事宜。上述制裁制度可能会对该基金的全球业务造成潜在合规和声誉风险，尤其是针对俄罗斯和中国的制裁。</li><li>代表一家美国科技跨国公司处理贸易合规调查，包括对可能未经授权向在美国商务部工业与安全局（BIS）《实体名单》上指定的中国军事研究机构转运该公司产品的指控进行的调查。</li><li>代表全球最大的对冲基金之一处理与美国对中国军工企业（CMIC）制裁制度相关的制裁合规问题。</li><li>代表一家在美国、中国及欧洲多个行业拥有重大投资的中东领先基金，根据中国《反外国制裁法》以及OFAC和BIS相关规定建立内部监管合规体系。</li><li>代表一家在中国拥有广泛运营的欧洲大型银行评估制裁和出口管制风险并建立制裁合规计划。</li><li>代表一家欧洲最大的金融机构处理其对香港关联方开展深入合规审查事宜，评估其反洗钱控制措施、风险管理及制裁应对框架、内部上报机制以及培训计划，以评定其是否符合美联储的相关法规。</li><li>代表一家领先的日本科技娱乐集团，就其在亚洲涉及中国和日本的业务的经济制裁、出口管制，以及反垄断审查合规问询，提供有时效性、深入的合规建议。</li><li>代表一家知名的美国科技和制造公司处理多项美国制裁合规事宜，包括涉及新疆的相关事宜，以及就可能明显违反多项美国制裁项目（例如涉及古巴和委内瑞拉的制裁项目）向OFAC进行的一系列自愿自行披露。</li><li>代表一家全球领先的电子测试与测量技术公司处理复杂的内部调查及与其中国业务相关的出口管制法规方面的合规事宜。</li><li>协助一家美国跨国能源公司促成其被外国政府离境控制的管理人员解除相关限制。 </li></ul><h5>诉讼和仲裁</h5><ul><li>代表一家领先的专业工具及汽车维修信息解决方案制造商，处理其针对一家中国竞争对手及其美国子公司在美国加州提起的商业机密盗窃仲裁及诉讼。</li><li>代表一家位于中国的云通信解决方案提供商的独立董事处理在美国提起的股东集体诉讼程序。</li><li>代表某大型国际银行的前雇员在美国的反垄断诉讼中处理书面证词事宜，该诉讼涉及操纵外汇价格的指控。</li><li>代表一家中国资产管理公司及其美国子公司处理在旧金山高等法院进行的股东纠纷诉讼。</li><li>代表一家中国大型保险集团公司及其美国子公司处理在美国特拉华州衡平法院审理的一项金额达40亿美元的商业合同纠纷，在特拉华州最高法院进行的上诉，以及同时在加州多个州法院进行的反欺诈调查事宜。</li><li>代表一家加拿大大型运输集团公司处理在美国伊利诺伊州中区地方法院进行的合同纠纷。</li></ul>

Derik Rao’s practice primarily focuses on compliance, regulatory, sanctions, export control, and white-collar matters, as well as investigations under the Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws.Derik assists clients in the technology, healthcare, finance, and other sectors in the U.S., China, Japan, and EU in managing regulatory and compliance risks. He works closely with the firm’s U.S., UK, and EU teams and represents clients in some of the most high-profile regulatory inquiries relating to the U.S. DOJ, OFAC, SEC, CFIUS, and China’s National Development and Reform Commission, Ministry of Commerce, and Cyberspace Administration of China, among other governmental authorities. He also helps multinational companies build their regulatory compliance programs in light of the emerging sanctions, export control, and other regulations. Derik delivers comprehensive risk assessments in connection with sanctions and national security matters involving Iran, Russia, Mainland China, Hong Kong, and other jurisdictions.Derik has extensive experience assisting leading healthcare, technology, industrial, investment portfolio, and consulting companies based in the U.S. and Europe in handling some of the most impactful internal investigations. His practice frequently involves whistleblower reports, compliance monitorships, self-disclosures, and negotiations with DOJ. He also has extensive experience investigating trending challenges faced by multinational companies, including anti-bribery, antitrust, data privacy, data exports, embezzlement, and accounting fraud.Additionally, Derik has advised NYSE-listed companies on their defense in securities class actions, regulatory investigations, and parallel lawsuits. He also defends individual clients based in Mainland China, Hong Kong, and Singapore in connection with U.S. criminal and civil lawsuits, including securities class actions, regulatory investigations, and criminal lawsuits involving wire fraud, insider trading, economic espionage, and theft of intellectual property.Prior to joining MoFo, Derik worked at a leading international law firm in Palo Alto, California, where he represented various leading technology companies in internal investigations and commercial litigation. He received his J.D. cum laude from Washington University in St. Louis. While in law school, he externed for a federal judge in Missouri and drafted multiple opinions. Before law school, Derik was a senior M&A consultant at a world-leading accounting firm.Derik is fluent in English and Mandarin.<h4>Representative Experience</h4><h5>Internal and Government Investigations</h5><ul><li>A world-leading U.S.-based pharmaceutical company in various internal investigations and remediation projects concerning its operations in China, South Korea, and EMEA.</li><li>A U.S.-based Fortune 500 healthcare company in various internal investigations concerning its operations in China involving anti-bribery, embezzlement, data privacy, and accounting fraud issues.</li><li>A leading Fortune 100 pharmaceutical company in an internal investigation in South Korea relating to donations to non-profit medical associations.</li><li>The audit committee of a semiconductor technology firm in an investigation into alleged fraud and related misconduct by former senior executives and employees.</li><li>One of the world’s leading music companies in a sensitive internal investigation involving its China subsidiary, which implicated potential criminal liability of the most senior managers of the subsidiary.</li><li>A European-listed global medical technology company’s China subsidiary in connection with anti-corruption and other compliance issues in China, Taiwan, and Hong Kong. The team systematically reviewed and enhanced the company’s compliance management regime, including its policies, procedures, and approval electronic systems.</li><li>A U.S.-based Fortune 200 company in the food and agricultural industry in an internal investigation into its China operations, covering issues such as improper benefits in connection with customer procurement, misappropriation of corporate funds, and expense fraud.</li><li>A world-leading professional services firm in internal and government investigations of alleged FCPA violations in China. The team successfully obtained a declination to prosecute from DOJ.</li><li>A leading Europe-based medical device company in the drafting of its compliance guidelines and conducting compliance training for its operations in China.</li><li>A Europe-based NASDAQ-listed healthcare company in a six-month compliance remediation project for its operations in China.</li><li>A leading NYSE-listed global supplier of coatings for various industrial applications in an internal investigation into allegations of bribery, corruption, self-dealing, bid rigging, collusion with distributors or suppliers, expense fraud, and other misconduct by the senior management of its China subsidiary.</li><li>A leading NYSE-listed, U.S.-based global supplier of chemicals in internal investigations concerning allegations of bribery, self-dealing, and misappropriation of company assets of its China employees.</li></ul><h5>National Security/Sanctions and Export Controls</h5><ul><li>One of the world’s largest AI technology companies based in the United States in various internal investigations, regulatory inquiries, and crisis management response strategies that involve issues across Chinese export controls, data privacy, national security reviews, and U.S. CFIUS reviews.</li><li>One of the largest financial institutions in China/Hong Kong in providing time-sensitive and complex compliance advice in relation to various economic sanctions regimes targeting China, including those imposed by the U.S. and EU. </li><li>Three of China's five major state-owned banks on U.S. sanctions, including responding to OFAC subpoenas, conducting internal investigations, and assessing transaction risks related to U.S. sanctions.</li><li>One of China’s largest state-owned multinational commercial banks in sanctions compliance matters relating to U.S. sanctions regimes targeting multiple jurisdictions, including Russia and China, and the resulting compliance and reputational risks to its global operations.</li><li>A U.S. multinational technology company in a trade compliance investigation involving allegations of potential unauthorized diversion of the company’s products to Chinese military research institutions designated on the U.S. BIS Entity List.</li><li>One of the world’s largest hedge funds in connection with sanctions compliance issues related to the Chinese Military-Industrial Complex (CMIC) sanctions regimes.</li><li>A leading Middle East fund with significant investments in various industries in the U.S., China, and Europe in establishing its internal regulatory compliance program under China’s Anti-Foreign Sanctions Law  and U.S. OFAC and BIS rules.</li><li>A large Europe-based bank with extensive operations in China in assessing sanctions and export control risks and establishing a sanctions compliance program.</li><li>One of the largest financial institutions in Europe in an in-depth compliance review of its Hong Kong affiliates, assessing anti-money laundering controls, risk management, and sanctions response frameworks, internal escalation mechanisms, and training programs to evaluate compliance with U.S. Federal Reserve regulations.</li><li>Provided a leading Japanese technology and entertainment conglomerate time-sensitive and in-depth compliance advice in relation to economic sanctions, export controls, and antitrust reviews for its Asia business involving China and Japan. </li><li>A prominent U.S. technology and manufacturing company in connection with various U.S. sanctions compliance issues, including with respect to Xinjiang and a series of voluntary self‑disclosures to OFAC that cover apparent violations of multiple U.S. sanctions programs (e.g., involving Cuba and Venezuela). </li><li>One of the world’s leading electronic test and measurement technology companies in complex internal investigations and compliance issues in relation to export control regulations relating to its operations in China.</li><li>An American multinational energy company in securing the lift of a border exit ban of its corporate executives by foreign governments.</li></ul><h5>Litigation and Arbitration</h5><ul><li>A leading manufacturer of professional tools and automotive repair information solutions in contentious trade secret theft arbitration and litigation matters pending in California against a China-based competitor and its U.S. subsidiary.</li><li>The independent directors of a China-based cloud communications solutions provider in shareholder class action proceedings filed in the United States.</li><li>A former employee of a major international bank in a deposition for a U.S. antitrust lawsuit alleging FX price fixing.</li></ul><ul><li>A Chinese asset management firm and its U.S. subsidiaries in certain shareholder dispute lawsuits before the San Francisco Superior Court.</li><li>A major Chinese insurance group company and its U.S. subsidiaries in a US$4 billion contract dispute trial before the Delaware Court of Chancery, the appeal before the Delaware Supreme Court, and parallel anti-fraud investigation matters before various California state courts.</li><li>A major Canadian transportation group company in a contract dispute before the U.S. District Court for the Central District of Illinois.</li></ul>

Derik Rao

Partner

Chuan Sun is Managing Partner of the Shanghai and Hong Kong offices.Chuan focuses his practice on cross-border M&A transactions; sophisticated technology, media, and telecom (TMT) transactions; and complex IP/commercial matters across Greater China.With more than 20 years of experience in both Asia and the U.S., Chuan regularly advises multinational corporations, state-owned enterprises, private companies, and PE/VC firms in complex cross-border M&A transactions, joint ventures, strategic alliances, and business separation transactions.Chuan has extensive experience in complex corporate-commercial and technology transactions across the Fintech, e-commerce, and broader TMT sectors. His work covers payment technology, eKYC, credit technology, blockchain, e-platform arrangements, R&D, co-development, technology collaborations, and IP licensing. He also advises on strategic outsourcing, manufacturing, distribution, supply, and franchising arrangements across various industries.Chuan regularly counsels clients on cutting-edge technology and IP regulatory matters, including Fintech, data privacy, cybersecurity, data localization, cross-border data transfers, cloud computing, telecommunications, telematics, and third-party payment services.Prior to joining MoFo, he worked in the Hong Kong office of a Magic Circle firm and the Chicago office of another leading international firm.Chuan co-authored the Hong Kong & mainland China chapters of Getting the Deal Through – Telecoms and Media, 2014, 2015 & 2016; the Hong Kong & mainland China chapters of Getting the Deal Through: Market Intelligence – Telecoms and Media, 2015; and the Hong Kong chapter of Sourcing World 2nd Edition 2015.Chuan is fluent in Mandarin and English.“Chuan Sun has a wealth of knowledge on his clients’ existing products and services offerings and a good understanding of what terms they are or are not willing to accept. This helps tremendously with contract negotiations.”“Chuan Sun has extensive experience in the technology space. Many other competitor firms in the technology space are not really pure IT lawyers, as they are more focus on privacy and trade marks or other related fields, as opposed to technology contracts such as SAP or Microsoft software license agreements. A normal general commercial lawyer would not be able to identify the same issues or raise the right questions, as they are not equipped with the technology know-how of the products and services, their benefits, and general industry standard terms and trending patterns in the market.” Legal 500 Asia Pacific 2020<h4>Representative Experience:</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li><li>OcuMension Therapeutics (HKSE: 01477), a Hong Kong Stock Exchange listed ophthalmic pharmaceutical platform in China in its acquisition of substantial assets valued at HK$1.28 billion (approximately US$165 million) from Alcon Inc., a global leader in eye care. The transaction involves asset purchase, global license, transition services and manufacture and supply arrangement and constitutes a very substantial transaction of OcuMension.</li><li>Ascendent Capital Partners in its US$1.66 billion privatization of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), a leading international automation control system solutions provider. This is a rare transaction where a PE fund successfully acquires a US-listed Chinese company without forming a consortium with controlling shareholder or management. It is also the first and only U.S. take-private of a BVI-incorporated company involving a dissenter process. </li></ul><ul><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with its first provision of blockchain and Real World Asset solutions in the fintech industry to a leading Chinese securities company for the latter’s first launch of structured product tokens, enabling secure, transparent, tamper-proof transactions for fixed-income and principal-protected tokenized products linked to US equity ETFs.</li><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with the international expansion of its various business operations that are based on cutting-edge technologies, including blockchain and crypto, into multiple jurisdictions. </li></ul>

孙川是美富上海办公室和香港办公室的管理合伙人。孙川律师的执业领域集中在大中华区的跨境并购交易，复杂的技术、媒体和电信(TMT)交易以及复杂的知识产权/商务事宜。孙律师在亚洲和美国有20多年工作经验，他经常代理跨国公司、国有企业、私人企业和私募股权/风险投资机构处理复杂的跨境并购交易、合资、战略联盟和业务拆分等交易。孙律师在战略性的公司商务和技术交易方面也拥有极为丰富的经验，包括外包、制造、分销、供应与特许经营安排，以及跨行业知识产权许可安排等。他在TMT和知识产权监管方面的经验包括电信、电子商务、互联网、网络安全、数据隐私、云计算以及车联网。在加入美富前，孙律师在一家 “魔法圈”律所(Magic Circle)的香港办事处和另一家领先的国际律所的芝加哥办事处工作。孙律师与他人合著了2014，2015和2016版《让交易推进下去––电信与媒体》(Getting the Deal Through – Telecoms and Media)中的香港和中国大陆章节，2015年版《让交易推进下去：市场情报––电信与媒体》(Getting the Deal Through: Market Intelligence – Telecoms and Media)中的香港和中国大陆章节，以及2015年《采购世界》第二版(Sourcing World 2nd Edition)的香港章节。2018年《亚太法律500强》指出“孙川律师十分高效、负责和实际。他非常擅长处理IT协议，包括软件许可和IT采购合同的相关事宜。他也十分善于处理跨境TMT交易。”孙律师精通普通话和英语。<h4>具有代表性的交易 </h4><ul><li>代表中国另类投资公司CPE源峰 就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li><li>代表香港上市的中国眼科制药平台欧康维视生物医药(HKSE: 01477)处理其收购全球眼科护理领域的领导者爱尔康公司价值 12.8 亿港元（约 1.65 亿美元）重大资产的事宜。交易涉及资产收购，以及全球许可、过渡期服务、生产和供应安排等，是欧康维视的一项非常重大交易。</li><li>代表上达资本处理其以16.6亿美元对和利时自动化技术有限公司（纳斯达克证券交易所股票代码：HOLI）进行私有化事宜。和利时是一家领先的国际自动化控制系统解决方案提供商。这是一宗罕见的交易。在这宗交易中，私募股权基金在未与控股股东或管理层组建财团的情况下，就成功收购了在美国上市的中国公司。这也是首宗且唯一一宗涉及异议股东程序的，在英属维尔京群岛注册成立的公司的美国上市公司私有化交易。</li><li>代表一家总部位于中国的全球领先金融科技公司首次为金融科技行业提供区块链及现实世界资产（RWA）解决方案，协助一家中国头部证券公司首次发行结构化产品代币。该方案为挂钩美国股票ETF的固定收益及保本型代币化产品提供了安全、透明且防篡改的交易支持‌。</li><li>代表一家总部位于中国的全球领先金融科技公司处理基于区块链和加密货币等尖端技术开展的各项业务在多个司法管辖区进行国际扩张的事宜。</li></ul>

Chuan Sun

Managing Partner, Shanghai and Hong Kong

Serena has been the Chair of the Greater China Private Funds practice since 2021 and served as the Deputy Chair of the firm’s Global Private Funds Group for four years. She represents global and regional fund managers and institutional investors in the formation of private equity, growth capital, venture capital, co-investment, and private credit funds across a wide range of sectors, including consumer, technology/TMT, financial services, and healthcare. Her representative fund manager clients include Affirma Capital, Ascendent Capital Partners, BAI Capital, Boyu Capital, CBC Group, DCP Capital, GLP, Hony Capital, KHL Capital, Kowloon Nights, Morgan Stanley Private Equity Asia, ORIX Asia Capital, Ping An, SoftBank Ventures Asia, and Taiwania Capital. Serena frequently advises fund managers on arrangements among principals, carried interest plans, employee co-investments, and regulatory and compliance matters. She also has deep experience in fund-of-funds, funds-of-one, and separate accounts.Serena advises real estate fund managers on the formation of real estate funds and joint ventures, with experience across asset classes, including offices, logistics, industrial parks, residential, hospitality, and retail. Her representative real estate fund manager clients include GLP, Hony Capital, SKP, and Sino-Ocean Capital.Serena also advises on GP-led and LP-led fund secondary transactions, including continuation vehicles, stapled secondaries, and secondary purchases of LP interests.In addition, Serena regularly represents institutional investors, including sovereign wealth funds, insurers, family offices, and asset management firms.Year after year, Serena is widely acknowledged by legal directories as one of the leading private funds partners in Asia. Recent recognition includes being ranked as a leading partner by Chambers Global (2019-2026), Chambers Asia-Pacific (2019-2021), Chambers Greater China (2022-2026), and Legal 500 Asia Pacific (2020-2026). She was featured in ALB’s “Asia’s 40 Under 40” list of the most accomplished young lawyers in 2018. Under Serena’s leadership, the Private Funds Team in Asia advised Asia-based GPs on more than 70 fund formation transactions in 2025, with an aggregate transaction value of US$122 billion. The team was also shortlisted for the 2021 PEI Awards for Asia Law Firm of the Year in the Fund Formation category.Serena has been recognized by clients as a “highly diligent and talented” practitioner with “excellent professional knowledge and a strong commercial sense” and their “go-to lawyer for fund formation work that has a Chinese component.” Clients have highlighted her as “an ideal partner” who “understands the differences between offshore funds and RMB funds and the differences between international investors and Chinese investors,” and “has the outstanding ability to design optimal structures, bridge gaps, and find solutions.”Serena is a Registered Foreign Lawyer (New York Qualified) with the Law Society of Hong Kong. She has over 17 years of experience practicing law in New York and China.

自2021年起，谭矿律师一直担任本所大中华区私募基金业务部主席，并曾连续四年担任本所全球私募基金业务组副主席。谭律师代表全球及区域性基金管理人和机构投资者处理设立私募股权基金、成长型资本基金、风险投资基金、共同投资基金和私募债权基金事宜，涵盖消费、技术/科技、媒体和电信（TMT）、金融服务以及医疗保健等众多行业。谭律师具代表性的基金管理人客户包括亚赋资本、上达资本、BAI资本、博裕资本、康桥资本、德弘资本、普洛斯、弘毅资本、达胜资本、Kowloon Nights、摩根士丹利亚洲私募股权、欧力士亚洲资本、平安、软银亚洲风投和台杉投资。此外，谭律师经常代表基金管理人处理负责人安排、收益分成计划、员工共同投资、监管与合规事宜。她在设立组合型基金、专项基金和基金专户相关事宜方面亦有丰富的经验。谭律师代表房地产基金管理人处理设立房地产基金及合资企业事宜，项目经验包括写字楼、物流、工业园区、住宅、酒店和零售等资产类别。谭律师具代表性的房地产基金管理人客户包括普洛斯、弘毅资本、SKP和远洋资本。谭律师还代表客户处理由普通合伙人主导以及由有限合伙人主导的基金二级市场交易，包括延续型基金、捆绑式二级交易以及在二级市场购买有限合伙人权益。此外，谭律师还经常代表包括主权财富基金、保险公司、家族办公室和资产管理机构在内的机构投资者处理相关事宜。谭律师连续多年获各大法律评级机构广泛认可，被评为亚洲顶级私募基金合伙人之一。她最近获得的殊荣包括被《钱伯斯全球法律指南》（2019-2026年）、《钱伯斯亚太法律指南》（2019-2021年）、《钱伯斯大中华区法律指南》（2022-2026）和《亚太法律500强》（2020-2026年）评为领先合伙人。她还于2018年荣登《亚洲法律杂志》“40位40岁以下杰出青年律师”榜单。在谭律师的带领下，本所亚洲私募基金团队在2025年代表亚洲普通合伙人处理了70多宗基金设立交易，交易总价值达1220亿美元。团队还入围了2021年PEI奖项中的基金设立类亚洲年度律所奖。 客户赞誉谭律师是位“极其勤勉且才华出众”的执业者、“具备丰富的专业知识和强烈的商业意识”、“处理涉华基金设立工作的最佳律师”。客户强调她是“理想的合作伙伴”、“深谙境外基金和人民币基金之间的差异以及国际投资者和中国投资者之间的差异”、“在设计最优结构、消除差异以及找到解决方案方面拥有非凡的能力。”谭律师是香港律师会注册外国律师。谭律师在纽约和中国有超过17年的法律执业经验。